Clinical Trial Update: Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update on renal sympathetic denervation as a treatment for therapy-resistant hypertension; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• Renal sympathetic denervation

Snippet

Sponsor: UMC Utrecht | Conditions: Hypertension, Chronic Kidney Disease | Phase 3 | Status: COMPLETED